about 34 cents a share is net value of ENMD (cash minus debt, remember they mortgaged the royalty revenue back in 2006). This is saying the patents are worthless (someone has a better mouse trap and we are too dumb to know about it, or a bigger, badder stock sale is looming.) I'm betting on 20 cents a share sometime soon. If you think I'm nuts go ahead and put your GTC order in now, big guy. Watch it get filled.
Wow, didn't see that coming. Market cap hovered at what, around $30 million total for a while.
Gee, guess anything can happen on low volume trades every hour. I wish I had a bid in. I am upset that the company has no news to report so close to October. But I still believe the science is just as logical as anywhere else and no major clinical trial results out yet for so many ongoing tests. All I can do is wait it out.